rs137852986
|
|
|
0.710 |
GeneticVariation |
BEFREE |
These results suggest that truncating variants in BRIP1, and in particular p.Arg798Ter, are not associated with a substantial increase in breast cancer risk.
|
26921362 |
2016 |
rs137852986
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
|
|
|
rs1292988272
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
|
29922827 |
2018 |
rs368796923
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
|
29922827 |
2018 |
rs775537066
|
|
CA |
0.700 |
CausalMutation |
CLINVAR |
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
|
29922827 |
2018 |
rs368796923
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
|
28152038 |
2017 |
rs587780228
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
|
28709830 |
2017 |
rs587780228
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
|
26681312 |
2016 |
rs587780236
|
|
TA |
0.700 |
CausalMutation |
CLINVAR |
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
|
27433846 |
2016 |
rs587780236
|
|
TA |
0.700 |
CausalMutation |
CLINVAR |
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
|
26681312 |
2016 |
rs587780833
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
|
26681312 |
2016 |
rs756853672
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.
|
26921362 |
2016 |
rs775171520
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer.
|
26824983 |
2016 |
rs775537066
|
|
CA |
0.700 |
CausalMutation |
CLINVAR |
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.
|
26921362 |
2016 |
rs786203700
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Inherited Mutations in Women With Ovarian Carcinoma.
|
26720728 |
2016 |
rs1057519365
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.
|
25058500 |
2015 |
rs1555616143
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
|
25186627 |
2015 |
rs1567878148
|
|
TA |
0.700 |
CausalMutation |
CLINVAR |
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
|
26315354 |
2015 |
rs587780833
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
|
26270727 |
2015 |
rs756853672
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
|
26315354 |
2015 |
rs775537066
|
|
CA |
0.700 |
CausalMutation |
CLINVAR |
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
|
26315354 |
2015 |
rs137852985
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
|
24366376 |
2014 |
rs137852985
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
|
24366402 |
2014 |
rs1057519365
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Mutations in BRIP1 confer high risk of ovarian cancer.
|
21964575 |
2011 |
rs1060501774
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Molecular basis of BACH1/FANCJ recognition by TopBP1 in DNA replication checkpoint control.
|
21127055 |
2011 |